There were 1,558 press releases posted in the last 24 hours and 241,805 in the last 365 days.
Global Autoinjector Contract Manufacturing Market Info
Global Autoinjector Contract Manufacturing Market seg
Global Autoinjector Contract Manufacturing Market will be valued at US$ 1.16 Billion in 2021. It is expected to reach US$ 2.80 Billion by 2030
NEW JERSEY, NJ, USA, September 13, 2022 /EINPresswire.com/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Autoinjector Contract Manufacturing Market- by Product (Disposable Autoinjectors, Reusable Autoinjectors, Wearable Injector and Smart/Connected Autoinjectors), Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis. Diabetes and Others), End-User (Homecare, Hospitals & Clinics and Ambulatory Services), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1340
According to the latest research by InsightAce Analytic, the global Autoinjector Contract Manufacturing market will be valued at US$ 1.16 Billion in 2021. It is expected to reach US$ 2.80 Billion by 2030, with a CAGR of 10.4% during a forecast period of 2022-2030.
Autoinjector devices make the rapid delivery of medications and antidotes possible, which people can even use without medical training. They are, therefore, efficient for managing emergencies and large numbers of casualties. For the self-administration of epinephrine (to prevent anaphylaxis), by migraine patients (to provide immediate pain relief), and for medical and emergency treatments, autoinjectors are frequently used. Patients with diseases requiring numerous daily injections are increasingly using autoinjectors.
The rise in cases of rheumatoid arthritis, multiple sclerosis, diabetes, and growth hormone abnormalities among patients is one of the main factors driving the autoinjector contract manufacturing market. Because they enable patients to inject their prescriptions without hesitation because of a phobia of the needle-based drug delivery technique, autoinjectors are becoming increasingly popular. Autoinjectors can be used anywhere without discomforting the user or anyone nearby. Because the device's main body does not need to be changed after each injection, autoinjectors reduce the user's cost per injection. The development of the autoinjector contract manufacturing business is being restrained by companies' increased R&D efforts to create easily accessible, economically viable, and cutting-edge technology-based autoinjectors for treating chronic illnesses. However, the preference for other methods of medication administration, such as oral diabetes medications and nasal epinephrine sprays, is projected to lessen the need for autoinjector devices. The market's growth is further constrained by the development of needle-free medication administration techniques such as jet injectors.
North America is anticipated to contribute to the Autoinjector Contract Manufacturing market majorly. Injections are a common treatment for many older people in the area, especially those with rheumatoid arthritis and diabetes. The major insurance programs in the area have also contributed to the growth of the market for Autoinjector Contract Manufacturing. In addition, the Asia Pacific Autoinjector Contract Manufacturing market is expected to register significant growth. The region's market is expanding primarily due to the high prevalence of diabetes and developing healthcare infrastructure, which has drawn several renowned autoinjector device manufacturers here.
Major market players operating in the Autoinjector Contract Manufacturing market include Phillips-Midsize (a Molex Company), Elcam Drug Delivery Devices (E3D) (Elcam Medical), Jabil Healthcare, Dali Medical Devices, Ypsomed Delivery Systems (YDS), SHL Medical, Haselmeier, Owen Mumford, Becton, Dickinson and Company (BD), CCBio, Nemera (Copernicus), Recipharm AB, Sonceboz, Solteam Medical, Stevanato Group, Union Medico ApS., Neuma Engineering, Emperra, Eitan Medical, Enable Injections, West Pharmaceutical Services, Inc., Delfi Medical, Wanchai Medical, and Other Prominent Player.
Recent collaborations and agreements in the market: • In June 2022, Sustainable medication delivery is becoming a higher concern for the pharmaceutical business, so Jabil Healthcare introduced the Xfinity autoinjector platform, a reusable and modular solution for subcutaneous (S.C.) drug self-administration. Through integrated sensors and electronics, the Qfinity+ autoinjector, a linked version of the handheld device, enables medical teams to monitor the treatment and compliance of their patients remotely. • In May 2021, The Aria Smart Autoinjector platform was introduced by Phillips-Medisize to foster innovation, distinctiveness, and sustainability in the digital drug-delivery device market. This most recent innovation will improve patient care with a smaller environmental impact thanks to a small, straightforward, smart injection device with a reusable electronic drive unit and single-use, disposable cassettes.
Curious about this latest version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/enquiry-before-buying/1340
Market Segments Global Autoinjector Contract Manufacturing Market, by Product, 2022-2030 (Value US$ Mn) • Disposable Autoinjectors • Reusable Autoinjectors • Wearable Injector • Smart/Connected Autoinjectors
Global Autoinjector Contract Manufacturing Market, by Application, 2022-2030 (Value US$ Mn) • Anaphylaxis • Rheumatoid Arthritis • Multiple Sclerosis • Diabetes • Others
Global Autoinjector Contract Manufacturing Market, by End-User, 2022-2030 (Value US$ Mn) • Homecare • Hospitals & Clinics • Ambulatory Services
Global Autoinjector Contract Manufacturing Market, by Region, 2022-2030 (Value US$ Mn) • North America • Europe • Asia Pacific • Latin America • Middle East & Africa
North America Autoinjector Contract Manufacturing Market, by Country, 2022-2030 (Value US$ Mn) • U.S. • Canada
Europe Autoinjector Contract Manufacturing Market, by Country, 2022-2030 (Value US$ Mn) • Germany • France • Italy • Spain • Russia • Rest of Europe
Asia Pacific Autoinjector Contract Manufacturing Market, by Country, 2022-2030 (Value US$ Mn) • India • China • Japan • South Korea • Australia & New Zealand
Latin America Autoinjector Contract Manufacturing Market, by Country, 2022-2030 (Value US$ Mn) • Brazil • Mexico • Rest of Latin America
Middle East & Africa Autoinjector Contract Manufacturing Market, by Country, 2022-2030 (Value US$ Mn) • GCC Countries • South Africa • Rest of Middle East & Africa
Why should buy this report: To receive a comprehensive analysis of the prospects for the global Autoinjector Contract Manufacturing market To receive an industry overview and future trends of the Autoinjector Contract Manufacturing market To analyze the Autoinjector Contract Manufacturing market drivers and challenges To get information on the Autoinjector Contract Manufacturing market value (US$ Mn) forecast to 2030 Significant investments, mergers & acquisitions in the Autoinjector Contract Manufacturing market industry
For More Information @ https://www.insightaceanalytic.com/customisation/1340
Priyanka Tilekar Insightace Analytic Pvt. Ltd. +1 551-226-6109 email us here
EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.
© 1995-2022 Newsmatics Inc. dba EIN Presswire All Right Reserved.